• Search
  • Advanced Search
Diabetes Metab J > Volume 32(2); 2008 > Article
Editorial
Korean Diabetes Journal 2008;32(2):98-101.
DOI: https://doi.org/10.4093/kdj.2008.32.2.98    Published online April 1, 2008.
Non-alcoholic Fatty Liver Disease and Adiponectin.
Kyung Mook Choi
Division of Endocrinology and Metabolism, Department of Internal Medicine, Korea University College of Medicine, Korea.
Abstract
No abstract available.
TOOLS
METRICS Graph View
  • 1 Crossref
  •   Scopus
  • 1,145 View
  • 15 Download
Related articles

Beyond Liver Disease: Non-Alcoholic Fatty Liver Disease and Advanced Liver Fibrosis in Kidney Disease2022 July;46(4)

Rho-Kinase as a Therapeutic Target for Nonalcoholic Fatty Liver Diseases2021 September;45(5)

Nonalcoholic Fatty Liver Disease: A Drug Revolution Is Coming2020 October;44(5)

Clinical Implication of Adiponectin.2008 April;32(2)

Rosiglitazone Activates AMPK and Improves Non-Alcoholic Fatty Liver Disease in OLETF Rats.2008 April;32(2)

ABOUT
BROWSE ARTICLES
FOR CONTRIBUTORS
Editorial Office
101-2104, Lotte Castle President, 109 Mapo-daero, Mapo-gu, Seoul 04146, Korea​
Tel: +82-2-714-9064    Fax: +82-2-714-9084    E-mail: diabetes@kams.or.kr                

Copyright © 2022 by Korean Diabetes Association.

Developed in M2PI

Close layer